Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

MedPAC report

This article was originally published in The Gray Sheet

Executive Summary

Medicare Payment Advisory Commission releases its semiannual 1report Feb. 27, including a recommendation for public reporting of financial relationships between physicians and device and drug firms (2"The Gray Sheet" Oct. 6, 2008, p. 10) and one to increase equipment utilization rate assumptions used to calculate Medicare payments for imaging scans (3"The Gray Sheet" Jan. 12, 2009, p. 12). Both proposals were finalized at previous meetings of the congressional advisory group and are similar to provisions that have made their way into pending legislative language. Imaging makers and doctors complain that the use assumption rate revision proposal, which would result in substantial per-scan payment reductions, is based on faulty data. The Access to Medical Imaging Coalition is pressing CMS to work with radiologists and manufacturers to assess actual use rates by collecting data from equipment scanning logs

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT027164

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel